Ilkka Kantola

Genetics, cardiac phenotype and cardiovascular outcomes in Fabry disease patients in Finland (2025)

ESC Heart Failure

Valtola, Kati; Pietilä‐Effati, Päivi; Männistö, Jonna M. E.; Walls, Susanne; Kantola, Ilkka; Kuusisto, Johanna

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire (2024)

Journal of Hypertension

Halimi Jean-Michel, Sarafidis Pantelis, Azizi Michel, Bilo Grzegorz, Burkard Thilo, Bursztyn Michael, Camafort Miguel, Chapman Neil, Cottone Santina, de Backer Tine, Deinum Jaap, Delmotte Philippe, Dorobantu Maria, Doumas Michalis, Dusing Rainer, Duly-Bouhanick Béatrice, Fauvel Jean-Pierre, Fesler Pierre, Gaciong Zbigniew, Gkaliagkousi Eugenia, Gordin Daniel, Grassi Guido, Grassos Charalampos, Guerrot Dominique, Huart Justine, Izzo Raffaele, Águila Fernando Jaén, Járai Zoltán, Kahan Thomas, Kantola Ilkka, Kociánová Eva, Limbourg Florian P., Lopez-Sublet Marilucy, Mallamaci Francesca, Manolis Athanasios, Marketou Maria, Mayer Gert, Mazza Alberto, MacIntyre Iain M., Mourad Jean-Jacques, Muiesan Maria Lorenza, Nasr Edgar, Nilsson Peter, Oliveras Anna, Ormezzano Olivier, Paixão-Dias Vitor, Papadakis Ioannis, Papadopoulos Dimitris, Perl Sabine, Polónia Jorge, Pontremoli Roberto, Pucci Giacomo, Robles Nicolás Roberto, Rubin Sébastien, Ruilope Luis Miguel, Rump Lars Christian, Saeed Sahrai, Sanidas Elias, Sarzani Riccardo, Schmieder Roland, Silhol François, Sokolovic Sekib, Solbu Marit, Soucek Miroslav, Stergiou George, Sudano Isabella, Tabbalat Ramzi, Tengiz Istemihan, Triantafyllidi Helen, Tsioufis Konstontinos, Václavík Jan, van der Giet Markus, Van der Niepen Patricia, Veglio Franco, Venzin Reto M., Viigimaa Margus, Weber Thomas, Widimsky Jiri, Wuerzner Grégoire, Zelveian Parounak, Zebekakis Pantelis, Lueders Stephan, Persu Alexandre, Kreutz Reinhold, Vogt Liffert; European Society of Hypertension Working Group on Hypertension, the Kidney

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Verenpainetaudin lääkehoito yksilöllistyy (2024)

Lääkärilehti

Vaura Felix, Palmu Joonatan, Suvila Karri, Lindroos Annika, Vuori Matti, Kantola Ilkka, Tornio Aleksi, Niiranen Teemu

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Hypertensio: primaarinen hypertensio (2024)

Kantola, Ilkka; Niiranen, Teemu

(D2 Artikkeli ammatillisessa kokoomateoksessa)

Clinical outcomes in patients switching from agalsidase beta to migalastat : A Fabry Registry analysis (2024)

Journal of Inherited Metabolic Disease

Pisani, Antonio; Wilson, Kathryn M.; Batista, Julie L.; Kantola, Ilkka; Ortiz, Alberto; Politei, Juan; Al-Shaar, Laila; Maski, Manish; Crespo, Ana; Ponce, Elvira; Linhart, Aleš

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Hemodynamic Bedside Monitoring Instrument with Pressure and Optical Sensors : Validation and Modality Comparison (2024)

Advanced Science

Kaisti Matti, Panula Tuukka, Sirkiä Jukka-Pekka, Pänkäälä Mikko, Koivisto Tero, Niiranen Teemu, Kantola Ilkka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney (2024)

Blood Pressure

Halimi, Jean-Michel; Sarafidis, Pantelis; Azizi, Michel; Bilo, Grzegorz; Burkard, Thilo; Bursztyn, Michael; Camafort, Miguel; Chapman, Neil; Cottone, Santina; de Backer, Tine; Deinum, Jaap; Delmotte, Philippe; Dorobantu, Maria; Doumas, Michalis; Dusing, Rainer; Duly-Bouhanick, Béatrice; Fauvel, Jean-Pierre; Fesler, Pierre; Gaciong, Zbigniew; Gkaliagkousi, Eugenia; Gordin, Daniel; Grassi, Guido; Grassos, Charalampos; Guerrot, Dominique; Huart, Justine; Izzo, Raffaele; Jaén Águila, Fernando; Járai, Zoltán; Kahan, Thomas; Kantola, Ilkka; Kociánová, Eva; Limbourg, Florian P.; Lopez-Sublet, Marilucy; Mallamaci, Francesca; Manolis, Athanasios; Marketou, Maria; Mayer, Gert; Mazza, Alberto; MacIntyre, Iain M.; Mourad, Jean-Jacques; Muiesan, Maria Lorenza; Nasr, Edgar; Nilsson, Peter; Oliveras, Anna; Ormezzano, Olivier; Paixão-Dias, Vitor; Papadakis, Ioannis; Papadopoulos, Dimitris; Perl, Sabine; Polónia, Jorge; Pontremoli, Roberto; Pucci, Giacomo; Robles, Nicolás Roberto; Rubin, Sébastien; Ruilope, Luis Miguel; Rump, Lars Christian; Saeed, Sahrai; Sanidas, Elias; Sarzani, Riccardo; Schmieder, Roland; Silhol, François; Sokolovic, Sekib; Solbu, Marit; Soucek, Miroslav; Stergiou, George; Sudano, Isabella; Tabbalat, Ramzi; Tengiz, Istemihan; Triantafyllidi, Helen; Tsioufis, Konstontinos; Václavík, Jan; van der Giet, Markus; der Niepen, Patricia Van; Veglio, Franco; Venzin, Reto M.; Viigimaa, Margus; Weber, Thomas; Widimsky, Jiri; Wuerzner, Gregoire; Zelveian, Parounak; Zebekakis, Pantelis; Lueders, Stephan; Persu, Alexandre; Kreutz, Reinhold; Vogt, Liffert

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

An expert consensus on the recommendations for the use of biomarkers in Fabry disease (2023)

Molecular Genetics and Metabolism

Burlina Alessandro, Brand Eva, Hughes Derralynn, Kantola Ilkka, Krӓmer Johannes, Nowak Albina, Tøndel Camilla, Wanner Christoph, Spada Marco

(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)

Long-term effectiveness of enzyme replacement therapy in Fabry disease with the p.Arg227Ter variant: Fabry disease in Ostrobothnia (FAST) study (2023)

American Journal of Medical Genetics Part A

Pietilä-Effati Päivi, Saarinen Jukka T, Löyttyniemi Eliisa, Saarenhovi Maria, Autio Reijo, Kantola Ilkka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study (2023)

Journal of Medical Genetics

Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhart A, Hughes DA, Hopkin RJ, Tøndel C, Langeveld M, Giraldo P, Pisani A, Germain DP, Mehta A, Deegan PB, Molnar MJ, Ortiz D, Jovanovic A, Muriello M, Barshop BA, Kimonis V, Vujkovac B, Nowak A, Geberhiwot T, Kantola I, Knoll J, Waldek S, Nedd K, Karaa A, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Sakov A, Warnock DG

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Ilkka

Kantola

Contact

Links

Areas of expertise

Publications

Sort by:

Genetics, cardiac phenotype and cardiovascular outcomes in Fabry disease patients in Finland (2025)

Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire (2024)

Verenpainetaudin lääkehoito yksilöllistyy (2024)

Hypertensio: primaarinen hypertensio (2024)

Clinical outcomes in patients switching from agalsidase beta to migalastat : A Fabry Registry analysis (2024)

Hemodynamic Bedside Monitoring Instrument with Pressure and Optical Sensors : Validation and Modality Comparison (2024)

Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney (2024)

An expert consensus on the recommendations for the use of biomarkers in Fabry disease (2023)

Long-term effectiveness of enzyme replacement therapy in Fabry disease with the p.Arg227Ter variant: Fabry disease in Ostrobothnia (FAST) study (2023)

Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study (2023)